Akanda (Akanda) EBIT : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Akanda EBIT?

Akanda's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $0.00 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Akanda's annualized ROC % for the quarter that ended in Dec. 2023 was 0.00%. Akanda's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 0.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Akanda's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 0.00%.

Akanda EBIT Historical Data

The historical data trend for Akanda's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akanda EBIT Chart

Akanda Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

-0.90

-1.66

-2.46

-8.12

-32.02

Akanda Quarterly Data
	Dec19	Sep20	Dec20	Jun21	Sep21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial					1.66	-	-	-	-

Competitive Comparison of Akanda's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Akanda's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akanda's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Akanda's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Akanda's EV-to-EBIT falls into.

Akanda EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Akanda (NAS:AKAN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Akanda's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	0 * ( 1 - 0% )	/	( (35.967	+	8.536)	/ 2 )
=	0	/	22.2515
=	0.00 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	36.508	-	9.672	-	( 0.713	-	max(0, 12.376	-	3.245	+	0.713	))
=	35.967

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	8.84	-	8.67	-	( 0.083	-	max(0, 10.172	-	1.806	+	0.083	))
=	8.536

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Akanda's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	0	/	( ( (11.783 + max(-7.504, 0))	+	(2.641 + max(-7.076, 0)) )	/	2 )
=	0	/	( ( 11.783	+	2.641 )	/	2 )
=	0	/	7.212
=	0.00 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.294	+	1.537	+	0.337)	-	(9.672	+	0	+	-1.7763568394003E-15)
=	-7.504

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.156	+	1.287	+	0.151)	-	(8.67	+	0	+	0)
=	-7.076

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Akanda's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	0	/	8.947
	=	0.00 %

Akanda EBIT Related Terms

Thank you for viewing the detailed overview of Akanda's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Akanda (Akanda) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (NAS:AKAN) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

Y230:Germany

Address

1A, 1B Learoyd Road, New Romney, GBR, TN28 8XU

Website

https://www.akandacorp.com

Akanda Corp is a cannabis cultivation, manufacturing and distribution company. The Company has three reportable segments: Cultivation, Distribution and Corporate. Cultivating activities comprise the cultivation segment is made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.